Ahmad Ubharay

2PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India.

Ajaykumar Singh, Vanita Noronha, Vijay Patil

|Dec 31, 2025
Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India.

Atul Tiwari, Ajay Kumar Singh, Vanita Noronha

Pageof 1